Skip to main content

NAPPSA Intelligence Center Source Standards

Needs ReviewEditorial status

View NAPPSA Resource Editorial Standards

Source Standards

NAPPSA Intelligence Center Source Standards

These standards explain the source categories, credibility tiers, and intended use of information surfaced in the NAPPSA Intelligence Center.

Source Credibility Tiers

  • Tier 1: NAPPSA-owned, official government, regulatory, public health, clinical trial, or peer-reviewed indexed sources.
  • Tier 2: Major journals, universities, professional associations, standards organizations, and scientific publishers.
  • Tier 3: Established industry news sources with editorial standards.
  • Tier 4: Sources requiring manual approval before inclusion.

Approved Source Categories

Source Section Tier Review Status
AJPPS.org AJPPS Research Center Tier 1 Pending source review
FDA Drug Updates Regulatory Intelligence Tier 1 Live in Intelligence Center; hourly cache
FDA Recalls and Safety Alerts Regulatory Intelligence Tier 1 Live in Intelligence Center; hourly cache
NIH News Releases Pharmaceutical Sciences / Research Tier 1 Live in Intelligence Center; hourly cache
MedlinePlus Health News Clinical Pharmacy Tier 1 Live in Intelligence Center; hourly cache
WHO News Global Health Tier 1 Live in Intelligence Center; hourly cache
BioPharma Dive Drug Development & Industry Intelligence Tier 3 Live in Intelligence Center; hourly cache
Fierce Pharma Pharma Market & Policy Tier 3 Live in Intelligence Center; hourly cache
ScienceDaily Pharmaceuticals Pharmaceutical Research Watch Tier 3 Live in Intelligence Center; hourly cache
ClinicalTrials.gov Clinical Trials Watch Tier 1 API integration recommended

Source Governance Rules

  1. Use only approved sources.
  2. Display original source attribution prominently.
  3. Use summaries and excerpts rather than republishing full articles.
  4. Prioritize NAPPSA-owned and official regulatory/scientific sources.
  5. Retire feeds that become unreliable, duplicative, sensational, or off mission.